论文部分内容阅读
作者测定了甲型肝炎患者、献血员和志愿者在自动、被动和自动被动联合免疫后的血清抗甲型肝炎病毒(HAV)抗体滴度,并提出预防暴露前、后甲型肝炎的抗-HAV免疫球蛋白的剂量应重新考虑。
The authors measured serum anti-hepatitis A virus (HAV) antibody titers in patients with hepatitis A, blood donors and volunteers after autoimmune, passive and auto-passive co-immunization and prophylactic treatment of hepatitis A and anti-HBV antibodies before and after exposure, The dosage of HAV immunoglobulin should be reconsidered.